Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: A case report about five patients

Minerva Anestesiologica

Volumn 79, Issue 7, 2013, Pages 758-761

  Taniguchi, T ^a   Sato, K ^a   Kurita, A ^a   Noda, T ^a   Okajima, M ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hemoperfusion; Methicillin resistant staphylococcus aureus; Shock, septic

Indexed keywords

ENDOTOXIN; HYPERTENSIVE FACTOR; POLYMYXIN B;

ADSORPTION; ADULT; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; DISEASE SEVERITY; FEMALE; HEMODYNAMICS; HEMOPERFUSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; SCORING SYSTEM; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; STAPHYLOCOCCUS AUREUS; SYSTOLIC BLOOD PRESSURE; TOXIC SHOCK SYNDROME;

ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HEMOPERFUSION; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POLYMYXIN B; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS;

EID: 84884696346     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1981;i:1017-21. (Pubitemid 11096622)
2. Thomas D, Withington PS: Toxic shock syndrome: a review of the literature. Ann R Coll Surg Eng 1985;67:156-8. (Pubitemid 15056883)
3. Silversides JA, Lappin E, Ferguson AJ. Staphylococcal toxic shock syndrome: mechanisms and management. Curr Infect Dis Rep 2010;12:392-400.
4. Hajjeh RA, Reingolg A, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979-1999. Emerg Infect Dis 1999;5:807-10. (Pubitemid 30022467)
5. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-52.
6. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47
7. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-7.
8. Nakazawa H, Nozaki M, Simoda K, Kikuchi Y, Honda T, Isago T. Successful management using combination therapy of endotoxin absorption therapy (PMX) and continuous hemodiafiltration (CVVHDF) or a critically ill burn patient suffering from methicillin-resistant Staphylococcus aureus toxic shock syndrome. Burns 2008;34:288-91. (Pubitemid 351163441)
9. Shore S, Nelson DP, Pearl JM, Manning PB, Wong H, Shanley TP et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 2001;88:591-4. (Pubitemid 32778518)
10. Wang Y, Liu Y, Sarker K, Nakashima M, Serizawa T, Kishida A. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-5. (Pubitemid 30151087)
11. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005;9:R653-R661.
12. Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V et al. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 2010;76:405-12.